Ginkgo Bioworks

Ginkgo Bioworks is a leading biotechnology platform that leverages AI, automation, and data analytics to program cells for a wide range of applications. It provides "biology-as-a-service," enabling partners in pharma, agriculture, and industrial sectors to accelerate their R&D and develop novel bio-based products.

Ligo Biosciences is a research-driven company that leverages generative AI models to design novel enzymes for industrial applications. Originating from Oxford University, they create custom biocatalysts for pharmaceuticals, fine chemical production, and food safety, accelerating innovation beyond the limits of naturally occurring enzymes.

Cradle is an AI-powered platform designed for scientists and biotech companies to engineer better proteins faster. By leveraging generative AI and machine learning, it helps generate novel protein candidates and optimize their properties, such as stability, activity, and binding affinity. The platform learns from your experimental data, enabling more breakthroughs in fewer lab experiments and significantly accelerating development timelines from years to quarters.

Tamarind Bio is an advanced computational platform that democratizes protein engineering. It provides scientists with a user-friendly interface and a powerful API to access state-of-the-art AI and physics-based tools like AlphaFold and RFdiffusion. The platform streamlines protein design, antibody engineering, and enzyme optimization, handling all high-performance computing and orchestration. This allows researchers to design novel molecules and improve biological variants at a massive scale, accelerating discovery in life sciences without requiring specialized computational expertise.

Culture Biosciences offers a cloud-based biomanufacturing platform that leverages AI and automation to accelerate bioprocess development. It provides remote access to a fleet of advanced bioreactors, enabling scientists to design, run, monitor, and analyze experiments from anywhere, significantly reducing R&D timelines and speeding up time-to-market for new bioproducts.

Ginkgo Bioworks is a leading biotechnology platform that leverages AI, automation, and data analytics to program cells for a wide range of applications. It provides "biology-as-a-service," enabling partners in pharma, agriculture, and industrial sectors to accelerate their R&D and develop novel bio-based products.

Ligo Biosciences is a research-driven company that leverages generative AI models to design novel enzymes for industrial applications. Originating from Oxford University, they create custom biocatalysts for pharmaceuticals, fine chemical production, and food safety, accelerating innovation beyond the limits of naturally occurring enzymes.

Cradle is an AI-powered platform designed for scientists and biotech companies to engineer better proteins faster. By leveraging generative AI and machine learning, it helps generate novel protein candidates and optimize their properties, such as stability, activity, and binding affinity. The platform learns from your experimental data, enabling more breakthroughs in fewer lab experiments and significantly accelerating development timelines from years to quarters.

Synthace is a life sciences R&D cloud platform combining software and expert consultation to accelerate drug discovery. It helps biology teams design, automate, and analyze complex experiments, such as assay development, using multifactorial methods and lab automation. This approach significantly reduces timelines, increases experimental throughput, and delivers more robust, reliable data for critical decision-making in biopharmaceutical research.

Tamarind Bio is an advanced computational platform that democratizes protein engineering. It provides scientists with a user-friendly interface and a powerful API to access state-of-the-art AI and physics-based tools like AlphaFold and RFdiffusion. The platform streamlines protein design, antibody engineering, and enzyme optimization, handling all high-performance computing and orchestration. This allows researchers to design novel molecules and improve biological variants at a massive scale, accelerating discovery in life sciences without requiring specialized computational expertise.

Culture Biosciences offers a cloud-based biomanufacturing platform that leverages AI and automation to accelerate bioprocess development. It provides remote access to a fleet of advanced bioreactors, enabling scientists to design, run, monitor, and analyze experiments from anywhere, significantly reducing R&D timelines and speeding up time-to-market for new bioproducts.

Variational AI leverages a generative AI foundation model, Enki™, to discover novel, drug-like small molecules. It accelerates drug discovery by generating selective lead structures in weeks, enabling biopharmaceutical partners to bypass traditional high-throughput screening and redefine the economics of therapeutic development.

Verge Genomics is a biotechnology company leveraging an all-in-human, AI-powered platform, CONVERGE®, to discover and develop drugs for complex diseases. By analyzing vast human genomic datasets, it aims to accelerate the creation of effective treatments for conditions like ALS, Parkinson's, and Frontotemporal Dementia, moving from discovery to clinic significantly faster than traditional methods.

1910genetics is a biotechnology company revolutionizing drug discovery with its multimodal AI platform, ITO™. Powered by lab automation, it accelerates the design of both small and large molecule therapeutics, aiming to make previously undruggable targets treatable for diseases like cancer, and neurological or autoimmune disorders.

Benchling is a cloud-based R&D platform for life sciences, using AI to accelerate scientific discovery. It unifies Electronic Lab Notebook (ELN), LIMS, and molecular biology tools to centralize data, streamline workflows, and enable collaboration for biotech and pharmaceutical research.

PipeBio is a specialized, cloud-based bioinformatics platform designed for antibody, TCR, and peptide discovery. It enables researchers to analyze, visualize, and manage large-scale sequence data, integrating seamlessly with functional assay results to accelerate biologics development. Acquired by Benchling, it offers an end-to-end solution for modern drug discovery.

Reshape Biotech provides an AI-powered lab automation platform that combines automated imaging hardware with a cloud-based analysis system. It's designed for R&D and QC labs in biotechnology, agriculture, and food science to automate plate imaging, analyze experiments with AI, and generate structured, reproducible data, significantly accelerating research and development cycles.

InsightAI is an AI-powered research assistant designed for the medical and life sciences fields. It streamlines the research process by generating scientific summaries, formulating hypotheses, creating experimental designs, and identifying potential drug targets. By integrating with peer-reviewed databases like PubMed, NIH Clinical Trials, and MyGene, InsightAI provides reliable, data-driven insights, saving researchers significant time on literature reviews and data analysis, thereby accelerating scientific discovery.

floatz is an AI-powered platform for the biotech and pharmaceutical industries, specializing in target validation and prioritization. It provides a "Foundational Evidence Audit" to de-risk R&D pipelines, using computational due diligence to assess the biological relevance and commercial viability of therapeutic targets, helping companies secure funding and make confident investment decisions.